Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 28,190,000 | 26,323,000 | 25,979,000 | 25,424,000 | 23,362,000 |
| Cost of Goods | 8,451,000 | 6,406,000 | 6,454,000 | 6,159,000 | 4,356,000 |
| Gross Profit | 19,739,000 | 19,917,000 | 19,525,000 | 19,265,000 | 19,006,000 |
| Operating Expenses | 11,842,000 | 10,351,000 | 11,886,000 | 10,126,000 | 9,332,000 |
| Operating Income | 7,897,000 | 9,566,000 | 7,639,000 | 9,139,000 | 9,674,000 |
| Interest Expense | 2,875,000 | 1,406,000 | 1,197,000 | 1,262,000 | 1,289,000 |
| Other Income | 2,833,000 | -814,000 | 259,000 | 256,000 | 753,000 |
| Pre-tax Income | 7,855,000 | 7,346,000 | 6,701,000 | 8,133,000 | 9,138,000 |
| Income Tax | 1,138,000 | 794,000 | 808,000 | 869,000 | 1,296,000 |
| Net Income Continuous | 6,717,000 | 6,552,000 | 5,893,000 | 7,264,000 | 7,842,000 |
| Net Income | $6,717,000 | $6,552,000 | $5,893,000 | $7,264,000 | $7,842,000 |
| EPS Basic Total Ops | 12.56 | 12.18 | 10.34 | 12.40 | 12.96 |
| EPS Basic Continuous Ops | 12.56 | 12.18 | 10.34 | 12.40 | 12.96 |
| EPS Diluted Total Ops | 12.49 | 12.11 | 10.28 | 12.31 | 12.88 |
| EPS Diluted Continuous Ops | 12.49 | 12.11 | 10.28 | 12.31 | 12.88 |
| EPS Diluted Before Non-Recurring Items | 18.65 | 17.69 | 17.10 | 16.60 | 14.82 |
| EBITDA(a) | $11,968,000 | $12,983,000 | $11,037,000 | $12,740,000 | $11,880,000 |